Ginsenoside compound K reduces neuronal damage and improves neuronal synaptic dysfunction by targeting Aβ

Background: Alzheimer’s disease (AD) is the most common neurodegenerative condition worldwide, with amyloid ß (Aβ) fibrils presenting as its main pathological feature. This study investigated whether Ginsenoside Compound K (CK) has activity against Aβ and its mechanism in reducing synaptic damage an...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Na, Pang, Qihang, Zhang, Yanhong, Lin, Jianan, Li, Hui, Li, Zhen, Liu, Yaxin, Fang, Xingyu, An, Yu, Bai, Haonan, Li, Dianyu, Cao, Zhanhong, Liu, Jian, Yang, Qing, Hu, Shaodan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977807/
https://www.ncbi.nlm.nih.gov/pubmed/36873999
http://dx.doi.org/10.3389/fphar.2023.1103012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977807/
https://www.ncbi.nlm.nih.gov/pubmed/36873999
http://dx.doi.org/10.3389/fphar.2023.1103012

Ejemplares similares